A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
Public ClinicalTrials.gov record NCT03880266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
Study identification
- NCT ID
- NCT03880266
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Journey Medical Corporation
- Industry
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Interventions
- Glycopyrronium cloth, 2.4% Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2019
- Primary completion
- May 23, 2019
- Completion
- May 23, 2019
- Last update posted
- Aug 24, 2021
2019
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Colorado Medical Research Center, Inc. | Denver | Colorado | 80210 | — |
| International Dermatology Research, Inc. | Miami | Florida | 33144 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Saint Louis University Dermatology | St Louis | Missouri | 63122 | — |
| Innovative Dermatology/ ACRC Trials | Plano | Texas | 75024 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03880266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03880266 live on ClinicalTrials.gov.